SMUP-IA-01

Phase 2 clinical trial has ended in Korea70%
70%

Intra-articular Injectable treatment for osteoarthritis

SMUP-IA-01, SMUP allogeneic umbilical cord blood-derived mesenchymal stem cells, is currently under development for the treatment and prevention of Osteoarthritis. Currently, Phase 2 clinical trial has ended in Korea

Mechanism of Action for SMUP-IA-01